Cardiac Function and Iron Chelation in Thalassemia Major and Intermedia: a Review of the Underlying Pathophysiology and Approach to Chelation Management
2009

Cardiac Function and Iron Chelation in Thalassemia

Sample size: 110 publication 10 minutes Evidence: moderate

Author Information

Author(s): Aessopos Athanasios, Berdoukas Vasilios

Primary Institution: University of Athens Medical School, Laiko Hospital

Hypothesis

The study investigates the relationship between cardiac function and iron overload in patients with thalassemia major and intermedia.

Conclusion

Adequate chelation therapy can significantly improve cardiac function and reduce the incidence of heart disease in thalassemia patients.

Supporting Evidence

  • Heart disease is the leading cause of mortality in beta-thalassemia.
  • Regular blood transfusions and iron chelation therapy are essential for managing thalassemia major.
  • Cardiac Magnetic Resonance findings guide chelation therapy.

Takeaway

Thalassemia can cause heart problems due to too much iron in the body, but with the right treatment, we can help keep the heart healthy.

Methodology

The study reviews existing literature and clinical findings related to cardiac function and iron overload in thalassemia patients.

Potential Biases

Potential bias in literature selection and interpretation of existing studies.

Limitations

The study primarily focuses on existing literature and may not include new experimental data.

Participant Demographics

Patients with thalassemia major and intermedia, predominantly from Mediterranean regions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.4084/MJHID.2009.002

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication